[Immediate results of combined treatment for soft tissue sarcomas including intraoperative radiation therapy].

Nowadays the most popular and justified, from oncological positions, method of treatment for soft tissue sarcomas is a combined approach with the use of conservative surgery followed by postoperative radiation therapy. In this regard, intraoperative radiation therapy (IORT) in a single dose of 10-20 Gy is a method that optimizes the role of radiation therapy in treatment of this pathology allowing precise localization of radiation zone within the "tumor bed", thereby minimizing damage of normal tissues and critical organs. The aim of the study was to investigate the effect of IORT on the frequency and structure of post-operative complications. Testing group (n = 49) was compared to the group without IORT (n = 57) and group with only surgery (n = 171). According to the study it was not obtained statistically significant differences in the incidence of postoperative complications in the groups (p = 0,57), not marked influence on the structure of post-operative complications.

[Prophylaxis of early radiation injuries to intact tissues following exposure to combined photon-neutron radiotherapy for malignant head and neck tumors].

Our data are presented on comparison of early- and late-response and complications in 320 patients with head and neck tumors after combined photon-neutron radiotherapy (CPNT) alone or in conjunction with cisplatin. Laser therapy via the LGN-222 quartz installation alternating with irradiation sessions was used to prevent and palliate radiation injuries. As a result, the incidence of acute (grade I-II) reactions was significantly lowered and severe fast-neutron-induced complications were avoided. Grade I (RTOG) skin and mucous membrane injuries were rarer in the main group receiving laser therapy (2.47%) as compared with controls (8.93%) (p < or = 0.02). Grade II injuries totaled 11.6% as compared with 5.57% in control (p < or = 0.02). No damage to skin and mucous membranes in grade III-IV (RTOG) was reported. Use of cisplatin was followed by a rise in frequency of both focal (90%) and diffuse (10%) film-coated membrane epithelite (p < or = 0.02). However, radiation-related response was aborted within 10-14 days after treatment in all cases. Our procedure may be used as a method of choice in prophylaxis of severe tissue damage and CPNT-induced complications.

[Role of fast neutrons in the treatment of soft tissue sarcoma].

The report deals with our data on evaluation of combined photon-neutron radiotherapy (CPNT) received by 33 patients with soft tissue sarcoma at the Clinic of the Urals Neutron Therapy Center. Follow-up ranged 10-80 months (median--68 months). Complete response was reported in 100% (control--45%). All the patients survived 12 months after treatment (control--85%); 5-year survival was 42 and 22%, respectively. Our modality appeared to be the only means of ionizing radiation dose dispensation in cases of early relapse after photon therapy when there was a glimmer of hope of stabilization.

[Long-term results of combined photon-neutron radiotherapy for malignant salivary gland tumors at the Ural Neutron Therapy Center].

An evaluation of combined photon-neutron radiotherapy (CPNT) of malignant tumors of the salivary gland (31) is presented. Overall 1-year survival was 100%, 2 years--95%, 3 years--65%, 4 years--57% and 5 years--47%. Radiation-related injury incidence did not vary dramatically: CPNT--15%, photon therapy--11%. Most relapse occurred within the first 24 months.

[Extended preoperative course of radiotherapy as component of combined and complex treatment of locally-advanced ampular rectal cancer].

Sixty-two patients were treated for locally-advanced ampular rectal cancer at the Center's Clinic (2004-2008). Extended preoperative course of radiotherapy plus 5 = fluorouracil chemomodification was given to 55 patients (group 1) and the same plus hyperthermia--to 27 (group 2). Radiation injuries were reported in 37.1% (group 1) and 29.6% in group 2. Surgical complications occurred in 10 (group 1) (32.2%) and 8 (group 2) (32%). Relapse was registered in 3 (group 1) (12.5%) and 3 (group 2) (13.6%). Overall 3-year survival (group 1)--82%; (group 2)--63.9%; 3-year relapse-free survival (group 1)--69.8%; (group 2)--52.2%.